We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies

Arl3.0

Argireline Research

Mostly mechanism / observational

6 peer-reviewed studies

What the evidence says

Mostly mechanism / observational

Most Argireline studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.

Most evidence is from mixed-quality randomised trials published 2002–2017.

Based on 6 studies · 3 RCTs

Confidence

Moderate confidence

By outcome

Skin healthModest reduction in the appearance of expression lines (cosmetic, not a health outcome) · 4-8 weeks
Mostly mechanism / observational3 studies

Older research base

Newest study from 2017

200220092017

1RCT2013

Lungu C, Considine E, Zahir S, Ponsati B, Arrastia S, Hallett M · Eur J Neurol (2013)

View source

2RCT2013

Wang Y, Wang M, Xiao S, Pan P, Li P, Huo J · Am J Clin Dermatol (2013)

View source

3RCT2017

In plain English: Our results confirm the antiwrinkle activity of acetyl hexapeptide-3. A significant decrease in TEWL with acetyl hexapeptide-3 treatment is observed.

Raikou V, Varvaresou A, Panderi I, Papageorgiou E. · J Cosmet Dermatol (2017)

Prospective, randomized controlled cosmetic-science study in 24 volunteers comparing acetyl hexapeptide-3, tripeptide-10-citrulline, their combination, and neither, over 60 days
Instrumental skin-microtopography measures (cR2, cR3) confirmed anti-wrinkle activity of acetyl hexapeptide-3
Acetyl hexapeptide-3 also significantly decreased transepidermal water loss (TEWL)

View source

4In Vitro2014

In plain English: the significant cytotoxicity of argireline solution was observed under 18 to 10 000 fold higher concentrations (depending on cells that were examined) in comparison to doxorubicin.

Grosicki M, Latacz G, Szopa A, Cukier A, Kieć-Kononowicz K. · Acta Biochim Pol (2014)

Independent in-vitro cytotoxicity study across HEK-293, IMR-32 neuroblastoma, and human primary skin fibroblasts
Anti-proliferative effects were dose-dependent but appeared only at 18- to 10,000-fold higher concentrations than the reference cytotoxin doxorubicin
Supports a wide topical safety margin for cosmetic-use concentrations

5In Vitro2002

In plain English: skin topography analysis of an oil/water (O/W) emulsion containing 10% of the hexapeptide on healthy women volunteers reduced wrinkle depth up to 30% upon 30 days treatment.

Blanes-Mira C, Clemente J, Jodas G, Gil A, Fernández-Ballester G, Ponsati B, Gutierrez L, Pérez-Payá E, Ferrer-Montiel A. · Int J Cosmet Sci (2002)

Foundational design paper: the hexapeptide Ac-EEMQRR-NH2 ('Argireline') was rationally designed to mimic the cosmetic action of botulinum toxin non-toxically
A 10% O/W emulsion reduced wrinkle depth up to ~30% over 30 days in a small, uncontrolled cohort of healthy women — an appearance measure, not a controlled trial
Mechanistically, the peptide inhibited neurotransmitter release with potency similar to BoNT-A but much lower efficacy, by interfering with SNARE-complex formation/stability

View source

6Review2007

In plain English: This article reviews the physiological basis and mechanism of action of the active cosmetic ingredient acetyl hexapeptide-8 (Argireline).

Ruiz MA, Clares B, Morales ME, Cazalla S, Gallardo V. · J Cosmet Sci (2007)

Review and formulation paper covering the physiological basis and mechanism of action of acetyl hexapeptide-8 as a cosmetic active
Frames Argireline explicitly as an anti-aging cosmetic ingredient incorporated into emulsions and gels for facial skincare
Emphasizes that delivery and stability in the cosmetic formulation are central to performance

View in Research Library

Argireline Research

Mostly mechanism / observational

Pilot study of topical acetyl hexapeptide-8 in the treatment for blepharospasm in patients receiving botulinum toxin therapy.

The anti-wrinkle efficacy of argireline, a synthetic hexapeptide, in Chinese subjects: a randomized, placebo-controlled study.

The efficacy study of the combination of tripeptide-10-citrulline and acetyl hexapeptide-3. A prospective, randomized controlled study.

The study of cellular cytotoxicity of argireline - an anti-aging peptide.

A synthetic hexapeptide (Argireline) with antiwrinkle activity.

Preparation and stability of cosmetic formulations with an anti-aging peptide.